Regeneron Pharmaceuticals Inc

REGN Common Stock USD0.001
Create an alert
Sell$762.58
Buy$763.18
$24.29 (3.29%)
Last updated today at 07:29 UTC
Trade

Key metrics

Open$726.69
Previous close$738.34
Market cap$72.91bn
P/E ratio17.17
Volume423,641
Dividend yield0.51%
EMS-

Company information

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue135.84m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share$0.94
  • Ex-dividend date20 May 2026
  • Payment date04 June 2026

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.